[1]
|
Johnson-Davis, K.L. (2018) Opiate & Benzodiazepine Confirmations: To Hydrolyze or Not to Hydrolyze is the Question. Journal of Applied Laboratory Medicine, 2, 564-572. https://doi.org/10.1373/jalm.2016.022947
|
[2]
|
Dou, C., Bournique, J.S., Zinda, M.K., Gnezda, M., McNally, A.J. and Salamone, S.J. (2001) Comparison of the Rates of Hydrolysis of Lorazepam-Glucuronide, Oxazepam-Glucuronide and Tamazepam-Glucuronide Catalyzed by E. coli Beta-D-Glucuronidase Using the On-Line Benzodiazepine Screening Immunoassay on the Roche/Hitachi 917 Analyzer. Journal of Forensic Sciences, 46, 335-340.
|
[3]
|
Meatherall, R. and Fraser, A.D. (1998) Comparison of Four Immunoassays for the Detection of Lorazepam in Urine. Therapeutic Drug Monitoring, 20, 673-675. https://doi.org/10.1097/00007691-199812000-00016
|
[4]
|
Taylor, L.L., Flint, N.A., Ma, V., Hill, B.M., Clark, C.J. and Strathmann, F.G. (2017) Internal Hydrolysis Indicator for Sample Specific Monitoring of β-Glucuronidase Activity. Journal of Analytical Toxicology, 41, 407-411. https://doi.org/10.1093/jat/bkx027
|
[5]
|
Meatherall, R.C. and Fraser, A.D. (1998) CEDIA dau Benzodiazepine Screening Assay: A Reformulation. Journal of Analytical Toxicology, 22, 270-273. https://doi.org/10.1093/jat/22.4.270
|
[6]
|
Beck, O., Lafolie, P., Odelius, G. and Boreus, L.O. (1990) Immunological Screening of Benzodiazepines in Urine: Improved Detection of Oxazepam Intake. Toxicology Letters, 52, 7-14. https://doi.org/10.1016/0378-4274(90)90160-N
|
[7]
|
Fenton, J., Schaffer, M., Chen, N.W. and Bermes Jr., E.W. (1980) A Comparison of Enzyme Immunoassay and Gas Chromatography/Mass Spectrometry in Forensic Toxicology. Journal of Forensic Sciences, 25, 314-319.
|
[8]
|
Morris, A.A., Chester, S.A., Strickland, E.C. and McIntire, G.L. (2014) Rapid Enzymatic Hydrolysis Using a Novel Recombinant β-Glucuronidase in Benzodiazepine Urinalysis. Journal of Analytical Toxicology, 38, 610-614. https://doi.org/10.1093/jat/bku083
|
[9]
|
Mina, A. (2020) Comparison of Several Immunoassays Used in Drugs of Abuse Screening: Assessment against Gold Standard Methods and Calculation of Measurement Uncertainty. Journal of Pharmacological and Toxicological Methods, 101, Article ID: 106649. https://doi.org/10.1016/j.vascn.2019.106649
|
[10]
|
DeRienz, R.T., Holler, J.M., Manos, M.E., Jemionek, J. and Past, M.R. (2008) Evaluation of Four Immunoassay Screening Kits for the Detection of Benzodiazepines in Urine. Journal of Analytical Toxicology, 32, 433-437. https://doi.org/10.1093/jat/32.6.433
|
[11]
|
Borrey, D., Meyer, E., Duchateau, L., Lambert, W., Van Peteghem, C. and De Leenheer, A. (2002) Enzymatic Hydrolysis Improves the Sensitivity of Emit Screening for Urinary Benzodiazepines. Clinical Chemistry, 48, 2047-2049. https://doi.org/10.1093/clinchem/48.11.2047
|
[12]
|
Darragh, A., Snyder, M.L., Ptolemy, A.S. and Melanson, S. (2014) KIMS, CEDIA, and HS-CEDIA Immunoassays Are Inadequately Sensitive for Detection of Benzodiazepines in Urine from Patients Treated for Chronic Pain. Pain Physician, 17, 359-66.
|
[13]
|
Dixon, R.B., Floyd, D. and Dasgupta, A. (2015) Limitations of EMIT Benzodiazepine Immunoassay for Monitoring Compliance of Patients with Benzodiazepine Therapy Even after Hydrolyzing Glucuronide Metabolites in Urine to Increase Cross-Reactivity: Comparison of Immunoassay Results with LC-MS/MS Values. Therapeutic Drug Monitoring, 37, 137-139. https://doi.org/10.1097/FTD.0000000000000117
|
[14]
|
Ruelius, H.W., Tio, C.O., Knowles, J.A., McHugh, S.L., Schillings, R.T. and Sisenwine, S.F. (1979) Diastereoisomeric Glucuronides of Oxazepam. Isolation and Stereoselective Enzymic Hydrolysis. Drug Metabolism & Disposition, 7, 40-43.
|
[15]
|
Fu, S., Lewis, J., Wang, H., Keegan, J. and Dawson, M. (2010) A Novel Reductive Transformation of Oxazepam to Nordiazepam Observed during Enzymatic Hydrolysis. Journal of Analytical Toxicology, 34, 243-251. https://doi.org/10.1093/jat/34.5.243
|
[16]
|
Fu, S., Molnar, A., Bowron, P., Lewis, J. and Wang, H. (2011) Reduction of Temazepam to Diazepam and Lorazepam to Delorazepam during Enzymatic Hydrolysis. Analytical and Bioanalytical Chemistry volume, 400, 153-164. https://doi.org/10.1007/s00216-011-4723-y
|
[17]
|
Pettersson Bergstrand, M., Meyer, M.R., Beck, O. and Helander, A. (2018) Human Urinary Metabolic Patterns of the Designer Benzodiazepines Flubromazolam and Pyrazolam Studied by Liquid Chromatography-High Resolution Mass Spectrometry. Drug Testing and Analysis, 10, 496-506. https://doi.org/10.1002/dta.2243
|
[18]
|
Salamone, S.J., Honasoge, S., Brenner, C., McNally, A.J., Passarelli, J., Goc-Szkutnicka, K., Brenneisen, R., El Sohly, M.A. and Feng, S. (1997) Flunitrazepam Excretion Patterns Using the Abuscreen OnTrak and OnLine Immunoassays: Comparison with GC-MS. Journal of Analytical Toxicology, 21, 341-345. https://doi.org/10.1093/jat/21.5.341
|
[19]
|
Beck, O., Lin, Z., Brodin, K., Borg, S. and Hjemdahl, P. (1997) The Online Screening Technique for Urinary Benzodiazepines: Comparison with EMIT, FPIA, and GC-MS. Journal of Analytical Toxicology, 21, 554-557. https://doi.org/10.1093/jat/21.7.554
|
[20]
|
Kuang, H., Li, Q., Shen, C., Xu, J., Yuan, Y., Xu, C. and Wang, W. (2009) A Highly Sensitive Method for the Determination of 7-Aminonitrazepam, a Metabolite of Nitrazepam, in Human Urine Using High-Performance Electrospray Liquid Chromatography Tandem Mass Spectrometry. Biomedical Chromatography, 23, 740-744. https://doi.org/10.1002/bmc.1178
|